Motoneuron-disease-like disorder after ganglioside therapy

[1]  T. Miyatake,et al.  Acute axonal polyneuropathy associated with anti‐GM1 antibodies following Campylobacter enteritis , 1990, Neurology.

[2]  G. Legname,et al.  Anti‐GM1 IgM antibodies in motor neuron disease and neuropathy , 1990, Neurology.

[3]  W. Bradley.  Critical review of gangliosides and thyrotropin‐releasing hormone in peripheral neuromuscular diseases , 1990, Muscle & nerve.

[4]  L. Berg,et al.  The spectrum of neurologic disease associated with anti‐GM1 antibodies , 1990, Neurology.

[5]  G. Parry,et al.  Lower motor neuron disease in a patient with auto‐antibodies against Gal(β 1‐3)GalNAc in gangliosides GM1 and GD1b , 1990, Neurology.

[6]  S. Horowitz.  Therapeutic strategies in promoting peripheral nerve regeneration , 1989, Muscle & nerve.

[7]  A. Pestronk,et al.  A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside , 1988, Annals of neurology.

[8]  E. Kabat,et al.  Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto‐N ‐tetraose associated with human motor neuron disease , 1988, Neurology.

[9]  Denise,et al.  Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGC1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy. , 1988, The Journal of biological chemistry.

[10]  A. Hays,et al.  Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease , 1986, Neurology.

[11]  Masaki Saito,et al.  Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides , 1976, Neuroscience Letters.

[12]  T. Miyatake,et al.  Axonal degeneration in the Guillain-Barré syndrome and anti-GM1 ganglioside antibodies. , 1992, Muscle & nerve.

[13]  D. Cornblath,et al.  Assessment of current diagnostic criteria for Guillain‐Barré syndrome , 1990, Annals of neurology.